Chlamydia trachomatis/ Neisseria gonorrhoeae | Back to Test Directory | ||||
Test Description |
|
||||
Nucleic acid amplification by TMA to detect Chlamydia trachomatis and/or Neisseria gonorrhoeae rRNA. | |||||
Performed | Avg. Turnaround Time | Method | |||
Coralville, 8 a.m. - 5 p.m., M - F |
1 - 3 business days | rRNA Amplification by TMA (Transcription-Mediated Amplification) | |||
Fee | CPT Code(s) | ||||
$113.60 | 87491, 87591 | ||||
Specimen Requirements | |||||
Specimen Type: | Preferred Specimen Types: Vaginal Swabs from Aptima Collection Device. Other acceptable specimen types: Urine, Pharyngeal (Throat) Swabs, or Rectal Swabs. | ||||
Patient Preparation: | For urine specimens, client should not have urinated for at least 1 hour prior to specimen collection. Vaginal specimens must be collected in a clinical setting. The specimen may be clinician or client (self)-collected. Self-collected vaginal specimens are an option for screening asymptomatic women. The instructions on this page are for self-collected swabs. Clients must read the Patient Collection Instructions before providing them with a collection kit. For clinician-collected specimens, the vaginal specimen should be collected before inserting a speculum if an exam is to occur. | ||||
Collection Instructions: | Collect samples using Aptima Mult-test or urine collection devices. Urine Specimen Collection (Male or Female): Client should not have urinated for at least 1 hour prior to specimen collection.
|
||||
Temperature and Stability: | Room Temperature; stable for 30 days (urine) and 60 days (swabs). | ||||
Unacceptable Conditions: | Specimens collected using anything other than Aptima collection kits or transport tubes. | ||||
Expected Results: | Chlamydia trachomatis rRNA: Positive, Negative, Equivocal, Invalid. Neisseria gonorrhoeae rRNA: Positive, Negative, Equivocal, Invalid. | ||||
Shipping Instructions | |||||
Wrap specimen container in absorbent material and place inside a biohazard bag. Transport specimen at room temperature. | |||||
Comments | |||||
SHL performs Chlamydia trachomatis and Neisseria gonorrhoeae screening using the Aptima Combo 2 Assay. Therapeutic failure or success cannot be determined with the APTIMA Combo 2 Assay since nucleic acid may persist following appropriate antimicrobial therapy. | |||||
Alternate Names | |||||
CT/GC; CT/NG |